REAL FERNANDEZ, FELICIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.100
EU - Europa 3.697
AS - Asia 2.298
SA - Sud America 216
Continente sconosciuto - Info sul continente non disponibili 136
AF - Africa 85
OC - Oceania 44
Totale 14.576
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.967
RU - Federazione Russa 1.083
PL - Polonia 820
IT - Italia 763
CN - Cina 613
SG - Singapore 604
HK - Hong Kong 314
SE - Svezia 261
IE - Irlanda 229
VN - Vietnam 204
KR - Corea 175
BR - Brasile 166
IN - India 124
CH - Svizzera 105
DE - Germania 97
FR - Francia 84
CA - Canada 78
FI - Finlandia 73
GB - Regno Unito 60
JP - Giappone 45
AU - Australia 44
ID - Indonesia 39
MX - Messico 34
JO - Giordania 30
BD - Bangladesh 29
NL - Olanda 27
IQ - Iraq 26
ZA - Sudafrica 26
UA - Ucraina 21
CI - Costa d'Avorio 19
ES - Italia 19
TR - Turchia 18
AT - Austria 14
NG - Nigeria 14
AR - Argentina 13
IR - Iran 13
AE - Emirati Arabi Uniti 11
CO - Colombia 11
EG - Egitto 11
CZ - Repubblica Ceca 10
DK - Danimarca 10
CL - Cile 8
EC - Ecuador 8
MY - Malesia 8
TH - Thailandia 6
PH - Filippine 5
AZ - Azerbaigian 4
BE - Belgio 4
CR - Costa Rica 4
IL - Israele 4
MA - Marocco 4
UZ - Uzbekistan 4
VE - Venezuela 4
GR - Grecia 3
GT - Guatemala 3
HN - Honduras 3
KZ - Kazakistan 3
LT - Lituania 3
NI - Nicaragua 3
NP - Nepal 3
PY - Paraguay 3
SV - El Salvador 3
TN - Tunisia 3
TW - Taiwan 3
AL - Albania 2
BG - Bulgaria 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EU - Europa 2
JM - Giamaica 2
KE - Kenya 2
LU - Lussemburgo 2
QA - Qatar 2
SA - Arabia Saudita 2
AF - Afghanistan, Repubblica islamica di 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
CY - Cipro 1
ET - Etiopia 1
GE - Georgia 1
GY - Guiana 1
HU - Ungheria 1
LB - Libano 1
LV - Lettonia 1
MN - Mongolia 1
PE - Perù 1
PK - Pakistan 1
PS - Palestinian Territory 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
ZW - Zimbabwe 1
Totale 14.442
Salva come PNG Salva come JPEG
Città #
Dallas 2.325
Santa Clara 1.364
Warsaw 809
Ashburn 686
Singapore 415
Fairfield 345
San Jose 258
Hong Kong 247
Dublin 223
Chandler 198
Woodbridge 196
North Bergen 182
Beijing 177
Seoul 167
Seattle 156
Milan 136
Houston 132
Cambridge 130
Florence 111
Wilmington 109
Council Bluffs 102
Bern 100
The Dalles 86
Lawrence 79
Hefei 73
Los Angeles 73
Altamura 72
Buffalo 70
Princeton 66
Lauterbourg 62
Ho Chi Minh City 61
New York 59
Rome 59
Boston 51
Hanoi 48
Mumbai 46
Ann Arbor 44
Moscow 38
Tokyo 38
Melbourne 36
Jakarta 30
Medford 28
Munich 28
San Diego 27
Brooklyn 26
Helsinki 26
Boardman 25
North Charleston 25
Shanghai 25
Clifton 24
Kent 20
Philadelphia 20
Abidjan 19
Phoenix 19
Turin 19
Chicago 18
Dong Ket 16
Redondo Beach 16
Toronto 16
Guangzhou 15
Hillsborough 15
Johannesburg 15
São Paulo 15
Jacksonville 14
London 14
Norwalk 14
Orem 13
Parma 13
Bologna 12
Montreal 12
Naples 12
Redwood City 12
Abuja 11
Amsterdam 11
Mexico City 11
Denver 10
Edmonton 10
Falkenstein 10
Baghdad 9
Chennai 9
Poplar 9
Ravenna 9
Vienna 9
West Lafayette 9
Atlanta 8
Barcelona 8
Columbus 8
Copenhagen 8
Da Nang 8
Dalian 8
Frankfurt am Main 8
Giza 8
Hillsboro 8
Stockholm 8
Turku 8
Andover 7
Bari 7
Bengaluru 7
Bethesda 7
Brno 7
Totale 10.472
Salva come PNG Salva come JPEG
Nome #
Therapeutic proteins immunogenicity: a peptide point of view 548
Antibodies from multiple sclerosis patients preferentially recognize hyperglucosylated adhesin of non-typeable Haemophilus influenzae 414
Cross-reactive peptide epitopes of Enterovirus Coxsackie B4 and human Glutamic Acid Decarboxylase detecting antibodies in Latent Autoimmune Diabetes in Adults versus Type 1 Diabetes 394
Immune dysfunction in Rett syndrome patients revealed by high levels of serum anti-N(Glc) IgM antibody fraction 381
The LIFE-MILCH study: first data on the exposure to Endocrine Disrupting Chemicals (EDCs) in urine and breast milk (BM) from end of pregnancy to 12 months of life. Abstract P1-245 ESPE 2024 62nd Annual Meeting of the European Society for Paediatric Endocrinology (ESPE) Liverpool, United Kingdom, November 16–18, 2024 379
Label-free method for anti-glucopeptide antibody detection in Multiple Sclerosis 357
Biosensor analysis of anti citrullinated protein/peptide antibodies (ACPA) affinity 330
The LIFE-MILCH project: preliminary data from the risk assessment model of exposure to Endocrine Disrupting Chemicals (EDCs) in mother-infant dyads during the first 3 months of life. ESPE 2024. Abstract RFC14, ESPE 2024 62nd Annual Meeting of the European Society for Paediatric Endocrinology (ESPE) Liverpool, United Kingdom, November 16–18, 2024 320
Modified Glycopeptides to Investigate Antigen-Antibody Interaction in Multiple Sclerosis 313
Alpha actinin is specifically recognized by multiple sclerosis autoantibodies isolated using an N-glucosylated peptide epitope 259
A Multiple N-Glucosylated Peptide Epitope Efficiently Detecting Antibodies in Multiple Sclerosis 257
A peptide-based anti-Adalimumab antibody assay to monitor immune response to biologics treatment in juvenile idiopathic arthritis and childhood chronic non-infectious uveitis 253
Anti-adalimumab antibodies in a cohort of patients with juvenile idiopathic arthritis: incidence and clinical correlations 250
An Optimised Di-Boronate-ChemMatrix Affinity Chromatography to Trap Deoxyfructosylated Peptides as Biomarkers of Glycation 250
Glycopeptide-Based Antibody Detection in Multiple Sclerosis by Surface Plasmon Resonance 239
Antibodies to post-translationally modified mitochondrial peptide PDC-E2(167-184) in type 1 diabetes 229
Role of Helical Structure in MBP Immunodominant Peptides for Efficient IgM Antibody Recognition in Multiple Sclerosis 228
Study of aberrant modifications in peptides as test bench to investigate the immunological response to non-enzymatic glycation 225
Aberrant post-translational modifications and autoimmunity: the case of Primary Biliary Cirrhosis 223
Antibody Recognition in multiple sclerosis and rett syndrome using a collection of linear and cyclic N-glucosylated antigenic probes 221
ANTIBODIES FROM MULTIPLE SCLEROSIS PATIENTS PREFERENTIALLY RECOGNIZE HYPER-GLUCOSYLATED ADHESIN OF NONTYPEABLE 219
Does an Aberrant Glucosylation Trigger Autoimmunity in Multiple Sclerosis? 212
SARS-CoV-2 inhibitory activity of a short peptide derived from internal fusion peptide of S2 subunit of spike glycoprotein 211
Optimization of Multiple Sclerosis Antigenic Probes by a Combinatorial Approach 209
Design, synthesis, and biological activity of tumor necrosis factor-alpha peptides for adalimumab recognition 208
Natural Triterpene Glycosides for Antibody Recognition 206
Detection of anti-adalimumab antibodies in a RA responsive cohort of patients using three different techniques 205
Glucopeptides derived from myelin-relevant proteins and hyperglucosylated nontypeable Haemophilus influenzae bacterial adhesin cross-react with multiple sclerosis specific antibodies: A step forward in the identification of native autoantigens in multiple sclerosis 200
N-glucosylated peptides of NogoR and OMGp proteins cross react with anti-hyperglucosylated adhesin of non-typeable Haemophilus influenzae antibodies in Multiple Sclerosis 199
Surface plasmon resonance method to evaluate anti-citrullinated protein/peptide antibody affinity to citrullinated peptides 198
CHARACTERIZATION OF RECOMBINANT HUMAN DOMAIN ANTIBODIES BY SURFACE PLASMON RESONANCE 197
Oleanane-type glycosides from the roots of Weigela florida "rumba" and evaluation of their antibody recognition 196
Surface Plasmon Resonance to Select and Characterize Recombinant Human Domain Antibodies. 195
DETECTION OF AUTOANTIBODIES IN PRIMARY BILIARY CIRRHOSIS USING PEPTIDES OF THE DIHYDROLIPOAMIDE ACETYLTRANSFERASE 194
The novel Boronic-ChemMatrix Resin to selectively fish out deoxyfructosylated peptides 194
Autoantibodies to N-glucosylated peptide sequons in Rett syndrome: the first insight to disclose an autoimmune mechanism. 193
Human recombinant domain antibodies against multiple sclerosis antigenic peptide CSF114(Glc) 193
Microwave-assisted reaction of building blocks for glycopeptides synthesis. 193
Role of Lipoylation of the Immunodominant Epitope of Pyruvate Dehydrogenase Complex: Toward a Peptide-Based Diagnostic Assay for Primary Biliary Cirrhosis 192
Modeling interaction between gp120 HIV protein and CCR5 receptor 191
Surface plasmon resonance-based methodology for anti-adalimumab antibody identification and kinetic characterization 191
Humoral response against LL-37 in psoriatic disease 189
Combinatorial approach to develop the optimal glycopeptide as molecular probe to characterize autoantibodies in Multiple Sclerosis. 186
N-glucosylated adhesin peptide-dendrimers: toward a selective apheresis for personalized treatment of multiple sclerosis. 186
Nuovi peptidi glicosilati 185
Histone Protein Epitope Mapping for Autoantibody Recognition in Rheumatoid Arthritis 184
Asparaginyl glucose is fundamental for autoantibody recognition in Multiple Sclerosis. 183
Interactions between Human Antibodies and Synthetic Conformational Peptide Epitopes: Innovative Approach for Electrochemical Detection of Biomarkers of Multiple Sclerosis at Platinum Electrodes 183
Synthetic peptides reproducing tissue transglutaminase-gliadin complex neo-epitopes as probes for antibody detection in celiac disease patients’ sera. 176
Electrochemical Glycopeptide Probes to Detect Autoantibodies in Multiple Sclerosis Patients’ Sera. 175
Surface plasmon resonance, fluorescence, and circular dichroism studies for the characterization of the binding of BACE-1 inhibitors 174
SPR-based biosensor analysis of autoantibodies from Rheumatoid Arthritis patients’ sera interacting with citrullinated Multiple Antigen Peptides 173
Synthesis, conformational analysis and biological activity evaluation of novel antiviral peptides blocking the SARS-CoV-2 cell-entry 167
Synthesis of organometallic glycopeptides and electrochemical studies to detect autoantibodies in multiple sclerosis patients´ sera. 166
A surface-plasmon resonance-based label-free in vitro serodiagnostic technology for multiple sclerosis. 165
Selective capture of anti‐N‐glucosylated NTHi adhesin peptide antibodies by a multivalent dextran conjugate 164
Anti-hyperglucosylated adhesin of non-typeable Haemophilus influenzae antibodies cross reacting with glucopeptides of NogoR and OMGp myelin proteins 164
Epitope mapping of N-terminal portion of tissue transglutaminase protein antigen to identify linear epitopes in celiac disease. 162
BIOSENSOR CHARACTERIZATION OF THE INTERACTION BETWEEN SYNTHETIC CITRULLINATED PEPTIDES AND AUTOANTIBODIES IN RHEUMATOID ARTHRITIS PATIENTS’ SERA 161
ELISA based on peptide antigens reproducing cross-reactive viral epitopes to detect antibodies in Latent Autoimmune Diabetes in Adults vs. Type 1 Diabetes 159
Interaction study of phospholipid membranes with an n-glucosylated β-turn peptide structure detecting autoantibodies biomarkers of multiple sclerosis 155
Characterisation of the minimal epitope detecting autoantibodies in Multiple Sclerosis by surface plasmon resonance 154
Structure-Activity Relationship Studies, SPR Affinity Characterization and Conformational Analysisof Peptides Mimicking the HNK-1 Carbohydrate Epitope 152
Is aberrant N-glucosylation relevant to recognise anti-MOG antibodies in Rett syndrome? 150
Hyperglucosylated adhesin-derived peptides as antigenic probes in multiple sclerosis: Structure optimization and immunological evaluation 143
Ferrocenyl Glycopeptides as Electrochemical Probes to Detect Autoantibodies in Multiple Sclerosis Patients’ Sera 142
INNOVATIVE ELECTROCHEMICAL DIAGNOSTIC DEVICES BASED ON SYNTHETIC CONFORMATIONAL PEPTIDE EPITOPE MIMICS 112
Totale 14.576
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.176
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.176
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022395 0 0 41 36 32 14 6 35 15 17 65 134
2022/20231.080 108 213 46 59 63 161 154 44 96 9 22 105
2023/2024431 28 41 66 20 21 39 27 100 10 22 25 32
2024/20253.454 115 304 176 460 1.002 624 59 130 193 120 140 131
2025/20266.049 396 2.584 438 256 467 176 457 153 259 213 158 492
2026/2027755 119 296 340 0 0 0 0 0 0 0 0 0
Totale 14.576